We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
HYDROmorphone Hydrochloride 1mg/mL oral solution, USP 473mL (Rhodes)
Section 19A approved medicine
HYDROmorphone Hydrochloride 1mg/mL oral solution, USP 473mL (Rhodes)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Current
Indication(s)
Hydromorphone hydrochloride preparations are indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or otherwise inappropriate to provide sufficient management of pain.
Additional information
Please note: CONTAINS SULFITES. Use of HYDROmorphone Hydrochloride 1mg/mL oral solution, USP 473mL (Rhodes) is contraindicated in patients with hypersensitivity to sulfite-containing medications.
Images
